Neubase Therapeutics
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Neubase Therapeutics
-
Lu par :
-
De :
À propos de ce contenu audio
Almost every human disease is driven by genetics. So what if we could cure every genetic disease, from Alzheimer's to cancer?
These may sound like lofty aspirations. But the team at Neubase Therapeutics has developed a method for temporarily modifying disease-causing genes without permanently altering the genome. The backbone of Neubase's technology is also highly adaptable. If successful, the company could only need to make small tweaks to develop a brand new therapy, avoiding years of difficult and expensive clinical trials.
Tune in to hear more about Neubase's cutting-edge approach and much more!
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in touch!
Fiona Mischel (Host)
- @SynBioBeta
- @FionaRMischel
- https://synbiobeta.com/
Neubase Therapeutics:
- @NeuBaseInc
- https://www.neubasetherapeutics.com/
Subscribe to the Built with Biology Digest for Spaces shows, news across the bioengineering world, upcoming events, and more!
Learn more about Race Against the Clock here!
Episode credits: Hosted by Fiona Mischel, produced by Nikita Michelsen, and recorded, edited, and engineered by Bryce Joseph-Nelson
Recorded: 9/22/21
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
